Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

China · Delayed Price · Currency is CNY

41.90

-2.62 (-5.89%)

Mar 4, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biopharmaceutical	896.44M	1.27B	2.27B	2.89B	2.32B
Biopharmaceutical Growth	-29.67%	-43.92%	-21.33%	24.74%	12.66%
Others	134.37M	135.77M	63.32M	79.01M	47.71M
Others Growth	-1.03%	114.42%	-19.86%	65.61%	204.69%
Total	1.03B	1.41B	2.34B	2.97B	2.36B
Total Growth	-26.92%	-39.63%	-21.29%	25.56%	14.11%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	751.77M	1.20B	1.70B	1.96B	1.76B
China Growth	-37.44%	-29.48%	-12.91%	11.05%	9.90%
Foreign	279.04M	208.74M	632.08M	1.01B	601.73M
Foreign Growth	33.68%	-66.98%	-37.49%	68.05%	28.55%
Total	1.03B	1.41B	2.34B	2.97B	2.36B
Total Growth	-26.92%	-39.63%	-21.29%	25.56%	14.11%

Source: S&P Global Market Intelligence.